Julia S. Caserto

Julia S. Caserto

Auto-generated profile, based on publicly available information

Julia S. Caserto

Robert Frederick Smith School of Chemical and Biomolecular Engineering, Cornell University, Ithaca, USA

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 March 2020 in Science Advances
Verified
Journal Article
Open access
PDF file
PKPreethi Korangath
Preethi Korangath
JBJames Barnett
James Barnett
ASAnirudh Sharma
Anirudh Sharma
EHElizabeth T. Henderson
Elizabeth T. Henderson
JSJacqueline Stewart
Jacqueline Stewart
Robert IvkovRobert Ivkov
Robert Ivkov
The factors that influence nanoparticle fate in vivo following systemic delivery remain an area of intense interest. Of particular interest is whether labeling with a cancer-specific antibody ligand (“active targeting”) is superior to its unlabeled counterpart (“passive targeting”). Using models of breast cancer in three immune variants of mice, we demonstrate that intratumor retention of antibody-labeled nanoparticles was determined by tumor-associated dendritic cells, neutrophils, monocytes, and macrophages and not by antibody-antigen interactions. Systemic exposure to either nanoparticle type induced an immune response leading to CD8+ T cell infiltration and tumor growth delay that was independent of antibody therapeutic activity. These results suggest that antitumor immune responses can be induced by systemic exposure to nanoparticles without requiring a therapeutic payload. We conclude that immune status of the host and microenvironment of solid tumors are critical variables for studies in cancer nanomedicine and that nanoparticle technology may harbor potential for cancer immunotherapy.

2 July 2022 in Nature Communications
Verified
Journal Article
Open access
PDF file
BWBo Wang
Bo Wang
JCJing Chen
Jing Chen
JCJulia S. Caserto
Julia S. Caserto
XWXi Wang
Xi Wang
MMMinglin Ma
Minglin Ma
Metabolic reprogramming of the tumor microenvironment (TME) and poor immunogenicity are two of the challenges that cancer immunotherapies have to overcome for improved clinical benefits. Among various immunosuppressive metabolites that keep anti-tumor immunity in check, the tryptophan catabolite kynurenine (Kyn) is an attractive target for blockade given its role in mediating immunosuppression through multiple pathways. Here, we present a local chemo-immunometabolic therapy through injection of a supramolecular hydrogel concurrently releasing doxorubicin that induces immunogenic tumor cell death and kynureninase that disrupts Kyn-mediated immunosuppressive pathways in TME. The combination synergically enhances tumor immunogenicity and unleashes anti-tumor immunity. In mouse models of triple negative breast cancer and melanoma, a single low dose peritumoral injection of the therapeutic hydrogel promotes TME transformation toward more immunostimulatory, which leads to enhanced tumor suppression and extended mouse survival. In addition, the systemic anti-tumor surveillance induced by the local treatment exhibits an abscopal effect and prevents tumor relapse post-resection. This versatile approach for local chemo-immunometabolic therapy may serve as a general strategy for enhancing anti-tumor immunity and boosting the efficacy of cancer immunotherapies.

1 January 2019 in International Journal of Hyperthermia
Verified
Journal Article
Open access
ASAnirudh Sharma
Anirudh Sharma
SÖSanem Özayral
Sanem Özayral
JCJulia S. Caserto
Julia S. Caserto
RCRosemarie Ten Cate
Rosemarie Ten Cate
NANicole M. Anders
Nicole M. Anders
Robert IvkovRobert Ivkov
Robert Ivkov
Purpose: A proposed mechanism for the enhanced effectiveness of hyperthermia and doxorubicin (Dox) combinations is increased intracellular Dox concentrations resulting from heat-induced cell stress. The purpose of this study was to determine whether specific varied Dox and heat combinations produce measurable effects greater than the additive combination, and whether these effects can be attributed to heat-induced increases in intracellular Dox concentrations. Methods: HCT116, HT29 and CT26 cells were exposed to Dox and water bath heating independently. A clonogenic survival assay was used to determine cell killing and intracellular Dox concentrations were measured in HCT116 cells with mass spectrometry. Cells were exposed to heating at 42 °C (60 min) and 0.5 µg/ml of Dox at varying intervals. Synergy was determined by curve-fitting and isobologram analysis. Results: All cell lines displayed synergistic effects of combined heating and Dox. A maximum synergistic effect was achieved with simultaneous cell exposure to Dox and heat. For exposures at 42 °C, the synergistic effect was most pronounced at Dox concentrations <0.5 µg/ml. Increased intracellular concentrations of Dox in HCT116 cells caused by heat-stress did not generate a concomitant thermal enhancement. Conclusions: Simultaneous exposure of HCT116 cells to heating and Dox is more effective than sequential exposure. Heat-induced cell responses are accompanied by increased intracellular Dox concentrations; however, clonogenic survival data do not support this as the cause for synergistic cytotoxicity.

5 September 2024 in Nature Sustainability
Verified
Journal Article
Closed access
PDF file
JCJulia S. Caserto
Julia S. Caserto
LWLyndsey Wright
Lyndsey Wright
CRCorey Reese
Corey Reese
MHMatthew Huang
Matthew Huang
MSMary K. Salcedo
Mary K. Salcedo
MMMinglin Ma
Minglin Ma

1 July 2021 in Bioactive Materials
Verified
Journal Article
Open access
MMMohamed Alaa Mohamed
Mohamed Alaa Mohamed
ASAref Shahini
Aref Shahini
NRNika Rajabian
Nika Rajabian
JCJulia Caserto
Julia Caserto
AEAhmed M.A. El-Sokkary
Ahmed M.A. El-Sokkary
CCChong Cheng
Chong Cheng
Biodegradable elastomers are important emerging biomaterials for biomedical applications, particularly in the area of soft-tissue engineering in which scaffolds need to match the physicochemical properties of native tissues. Here, we report novel fast photocurable elastomers with readily tunable mechanical properties, surface wettability, and degradability. These elastomers are prepared by a 5-min UV-irradiation of thiol-ene reaction systems of glycerol tripentenoate (GTP; a triene) or the combination of GTP and 4-pentenyl 4-pentenoate (PP; a diene) with a carefully chosen series of di- or tri-thiols. In the subsequent application study, these elastomers were found to be capable of overcoming delamination of myotubes, a technical bottleneck limiting the in vitro growth of mature functional myofibers. The glycerol-based elastomers supported the proliferation of mouse and human myoblasts, as well as myogenic differentiation into contractile myotubes. More notably, while beating mouse myotubes detached from conventional tissue culture plates, they remain adherent on the elastomer surface. The results suggest that these elastomers as novel biomaterials may provide a promising platform for engineering functional soft tissues with potential applications in regenerative medicine or pharmacological testing.